ArticleNuklearmedizin. Nuclear medicine2026

177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public.

Christian Schütze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.